61 related articles for article (PubMed ID: 27732737)
1. Tyrosine kinase inhibitor TKI-258 inhibits cell motility in oral squamous cell carcinoma in vitro.
Carneiro ACDM; Silveira ICD; Rezende AS; Silva BRO; Crema VO
J Oral Pathol Med; 2017 Aug; 46(7):484-488. PubMed ID: 27732737
[TBL] [Abstract][Full Text] [Related]
2. Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro.
Silveira IC; Carneiro ACDM; Hiss LS; Crema VO
Anticancer Agents Med Chem; 2020; 20(6):751-755. PubMed ID: 32053087
[TBL] [Abstract][Full Text] [Related]
3. HA-1077 inhibits cell migration/invasion of oral squamous cell carcinoma.
Moreira Carboni Sde S; Rodrigues Lima NA; Pinheiro NM; Tavares-Murta BM; Crema VO
Anticancer Drugs; 2015 Oct; 26(9):923-30. PubMed ID: 26181228
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
[TBL] [Abstract][Full Text] [Related]
5. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells.
Hamada M; Miki T; Iwai S; Shimizu H; Yura Y
Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab has an inhibitory effect on cell motility in SCC-4 oral squamous cell carcinoma cell line.
Furtado LM; Da Silveira IC; Carneiro ACDM; Zehuri MMON; Carboni SSCM; Tavares-Murta BM; Crema VO
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):13-17. PubMed ID: 28980916
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
8. RhoA/ROCKs signaling is increased by treatment with TKI-258 and leads to increased apoptosis in SCC-4 oral squamous cell carcinoma cell line.
Carneiro ACDM; De Vito FB; Moraes-Souza H; Crema VO
J Oral Pathol Med; 2021 Apr; 50(4):394-402. PubMed ID: 33222274
[TBL] [Abstract][Full Text] [Related]
9. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
[TBL] [Abstract][Full Text] [Related]
10. Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling.
Donnini S; Monti M; Castagnini C; Solito R; Botta M; Schenone S; Giachetti A; Ziche M
Int J Cancer; 2007 Mar; 120(5):995-1004. PubMed ID: 17131343
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
12. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
[TBL] [Abstract][Full Text] [Related]
14. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.
Brusevold IJ; Aasrum M; Bryne M; Christoffersen T
J Oral Pathol Med; 2012 Aug; 41(7):547-58. PubMed ID: 22413835
[TBL] [Abstract][Full Text] [Related]
15. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
Li P; Xiao LY; Tan H
Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
[TBL] [Abstract][Full Text] [Related]
16. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
17. Invadopodia formation in oral squamous cell carcinoma: the role of epidermal growth factor receptor signalling.
Hwang YS; Park KK; Chung WY
Arch Oral Biol; 2012 Apr; 57(4):335-43. PubMed ID: 21920495
[TBL] [Abstract][Full Text] [Related]
18. Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells.
Kitajo H; Shibata T; Nagayasu H; Kawano T; Hamada J; Yamashita T; Arisue M
Oncol Rep; 2003; 10(5):1351-6. PubMed ID: 12883706
[TBL] [Abstract][Full Text] [Related]
19. Is there a pAkt between VEGF and oral cancer cell migration?
Islam MR; Jones SJ; Macluskey M; Ellis IR
Cell Signal; 2014 Jun; 26(6):1294-302. PubMed ID: 24561239
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
